A Randomized, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study of DSP-1747 in Patients with Nonalcoholic Steatohepatitis
Phase 2
- Conditions
- onalcoholic Steatohepatitis
- Registration Number
- JPRN-jRCT2080221948
- Lead Sponsor
- Sumitomo Dainippon Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients with Nonalcoholic Steatohepatitis based on the liver biopsy
-Outpatients
etc.
Exclusion Criteria
- Patients with significant alcohol consumption
- Patients with complication by other chronic liver disease
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Histological improvement<br>Last observation
- Secondary Outcome Measures
Name Time Method Change in indicators of hepatic function<br>Change in disease markers<br><br>Last observation